$PTOS Balance Sheet | Understand Stock

$PTOS

$0.01 -$0.00 (9.46%) Close

$PTOS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In USD, except per-share amounts

	Q4 FY2025 As of Mar 31, 2025	Q3 FY2025 As of Dec 31, 2024	Q2 FY2025 As of Sep 30, 2024	Q1 FY2025 As of Jun 30, 2024	Q4 FY2024 As of Mar 31, 2024	Q3 FY2024 As of Dec 31, 2023	Q2 FY2024 As of Sep 30, 2023	Q1 FY2024 As of Jun 30, 2023	Q4 FY2023 As of Mar 31, 2023	Q2 FY2015 As of Sep 30, 2014	Q1 FY2015 As of Jun 30, 2014	Q4 FY2014 As of Mar 31, 2014	Q3 FY2014 As of Dec 31, 2013	Q2 FY2014 As of Sep 30, 2013	Q1 FY2014 As of Jun 30, 2013	Q4 FY2013 As of Mar 31, 2013	Q3 FY2013 As of Dec 31, 2012	Q2 FY2013 As of Sep 30, 2012	Q4 FY2012 As of Mar 31, 2012	Q3 FY2012 As of Dec 31, 2011
Current Assets
Cash
Receivables
Prepaid Assets
Security for Legal Costs PVT
Costs on uncompleted contract
Advances

Cash
Accounts receivable
Other receivable
Prepaid expense
Total Current Assets
Hydro Projects
Total Long Term Assets
Goodwill
TOTAL ASSETS
Current Liabilities
Bank Indebtedness, current
Accounts Payable
Unearned Income
Accrued Liabilities
Loan Payable, Current
Warrant Derivative Liability
Bank indebtedness
Accounts payable and accrued liabilities
Accrued interest
Promissory notes payable
Convertible notes payable
Due to related parties

Contingent consideration liability
Contingent consideration liability
Total Current Liabilities
Loans Payable
Due to Related Parties
Contingent consideration liability - non-current
Total Liabilities
Stockholders' Deficit
Common stock, $0.001 par value; 500,000,000 shares authorized, 127,009,013 shares and 67,946,513 shares issued and outstanding, respectively
Additional paid-in capital
Preferred Stock
Preferred Stock Additional Paid in Capital
Share Subscriptions
Other Comprehensive Loss
Foreign Exchange Reserve
Accumulated deficit
Accumulated other comprehensive loss
Deficit Accumulated during Development Stage

Preferred stock, par value
Preferred stock, shares authorized
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Total Stockholders' Deficit
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

Comments